A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Completed · Phase 4

Conditions studied: Acne Vulgaris

In brief

A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).

Key facts

Study ID

NCT01231334

Run by

Allergan

People needed

286

Starts

2010-08-01

Expected to finish

2011-06-01

Last updated by the study team

2012-07-27

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Severe facial acne (acne vulgaris)

You may not qualify if…

• History of significant anemia or hemolysis
• History of enteritis (eg, regional enteritis, ulcerative colitis, pseudomembranous colitis, antibiotic-associated colitis)
• History of lupus, rosacea, or seborrheic dermatitis

Where it is running

• Study site — Miramar, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.